Generic Drugs Market Poised for Robust Growth, Expected to Reach $615.72 Billion by 2030

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Generic drugs, which are identical to their brand-name counterparts in dosage, strength, administration route, quality, and intended use but are typically sold at lower prices, are becoming increasingly popular. The market is flourishing as more patents for brand-name drugs expire, allowing for the production and sale of cost-effective generic alternatives. Additionally, the growing elderly population worldwide, which is more susceptible to chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders, is fueling demand.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞:

The global generic drugs market, valued at $431.15 billion in 2023, is projected to reach an impressive $615.72 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.22%. This significant expansion is driven by the increasing prevalence of chronic diseases, patent expirations of branded medications, and rising global healthcare costs.

𝐔𝐧𝐜𝐨𝐯𝐞𝐫 𝐈𝐧-𝐃𝐞𝐩𝐭𝐡 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: https://www.maximizemarketresearch.com/request-sample/25900/

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬:

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

𝐓𝐡𝐞 𝐝𝐲𝐧𝐚𝐦𝐢𝐜𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐠𝐞𝐧𝐞𝐫𝐢𝐜 𝐝𝐫𝐮𝐠𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞 𝐬𝐡𝐚𝐩𝐞𝐝 𝐛𝐲 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐤𝐞𝐲 𝐟𝐚𝐜𝐭𝐨𝐫𝐬:

Rise in Chronic Diseases: The increasing incidence of chronic illnesses is a major driver. As more individuals are diagnosed with conditions requiring long-term treatment, the demand for affordable medication options rises. According to the World Health Organization (WHO), fatalities due to chronic diseases are expected to increase by 17% over the next decade, with these diseases accounting for nearly three-quarters of all deaths globally by 2022.

Cost-Effectiveness: Generic drugs are significantly cheaper than branded medications, making them a preferred choice for patients, particularly those with chronic conditions requiring prolonged treatment.

Intermediary Influence: Despite the lower prices of generic drugs, patients often do not fully benefit from these savings due to the involvement of intermediaries like pharmacy benefit managers (PBMs) and insurers. Practices such as spread pricing and profit-driven formulary design can lead to overpayment for generic medications, impacting their prescription rates.

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

North America: Dominating the market with a 33.21% share in 2023, North America's high income from generic drugs is attributed to the presence of numerous key players and a prescription pattern favoring branded generic pharmaceuticals.

Asia Pacific: Expected to grow at the highest CAGR of 6.42%, this region benefits from lower manufacturing costs and a skilled workforce. India, for example, has the second-largest number of FDA-approved generic drug manufacturing plants outside the U.S., with production costs significantly lower than in the U.S.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐚𝐧𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬

Major players in the generic drugs market are leveraging strategic initiatives to drive growth. For instance:

Pfizer Inc.: In June 2022, Pfizer announced the submission of a New Drug Application (NDA) to the U.S. FDA for PAXLOVID™, targeting patients at high risk of severe illness from COVID-19.
Teva Pharmaceuticals Industries Ltd.: In May 2023, Teva revealed plans to showcase data on UZEDY, an extended-release injectable suspension for subcutaneous use.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) : https://www.maximizemarketresearch.com/request-sample/25900/

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

♦ 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Simple Generics
Super Generics
Biosimilars

The global market for generic medications is divided into three segments based on the product: biosimilars, super generics, and simple generics. In 2023, the Super Generics category had the most market share, accounting for almost 38%. Super generic medications are referred to as hybrids, value enhanced generics, and unique therapeutic entities. Super generic products are not the same as the original product in terms of composition or distribution method. The clinical effect of biosimilars is equivalent to that of generics, but their similarity to the original branded drug is limited by validation technology. As biosimilar developers concentrate on increasingly complicated proteins that require even more advanced production processes and higher costs, they will be forced to follow established protocols for demonstrating a high degree of similarity.

♦ 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Cardiovascular Products
Anti-Infective Drugs
Anti-Arthritis Drugs
Central Nervous System Drugs
Anti-Cancer Drug
Respiratory Products
Others

The global market for generic medications is divided into several segments based on its application, including cardiovascular products, anti-infective drugs, anti-arthritis drugs, drugs for the central nervous system, anti-cancer therapies, respiratory products, and others. The category with the biggest market share in 2023 was drugs for the central nervous system. Improved access to healthcare options, societal acceptance of mentally ill people, and growing awareness of mental health issues are some of the key factors expected to propel market expansion. Generic medication market growth is anticipated to be driven by affordable and easily accessible pharmaceuticals throughout the forecast period.

♦ 𝐛𝐲 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥

Hospitals
Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
Others

𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

1. Mylan N.V. - (USA)
2. Par Pharmaceuticals- (USA)
3. Pfizer - (USA)
4. Baxter International Inc. - (USA)
5. Eli Lilly and Company - (USA)
6. Abbott Laboratories - (USA)
7. Apotex Inc. - (Canada)
8. Apotex Corp. - (USA)

𝐄𝐮𝐫𝐨𝐩𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

1. Endo Pharmaceuticals - (Ireland)
2. Teva Pharmaceutical Industries Ltd- (Israel)
3. STADA Arzneimittel AG - (Germany)
4. GlaxoSmithKline Plc. - (United Kingdom)
5. Novartis International AG - (Switzerland)

𝐀𝐏𝐀𝐂 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

1. Sun Pharma - (India)
2. Lupin Pharmaceuticals - (India)
3. Dr Reddy's - (India)
4. ASKA Pharmaceutical Co., Ltd. - (Japan)
5. Taisho Pharmaceutical Holdings Co Ltd - (Japan)
6. Aurobindo Pharma Limited - (India)
7. Hikma Pharmaceuticals PLC - (Jordan)
8. Torrent Pharmaceuticals Ltd - (India)

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤

The global generic drugs market is set for robust growth, driven by technological advancements, strategic initiatives by key players, and a growing focus on affordable healthcare solutions. As the market continues to evolve, addressing intermediary influences and enhancing accessibility to cost-effective generic medications will be crucial for sustained growth.

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐟𝐨𝐫 𝐚𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐬𝐭𝐮𝐝𝐲 : https://www.maximizemarketresearch.com/market-report/global-generic-drugs-market/25900/

𝐊𝐞𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐬:

What is Generic Drugs ?
What is the growth rate of the Generic Drugs Market?
Which are the factors expected to drive the Generic Drugs market growth?
What is the CAGR at which the Generic Drugs market will grow during the forecast period?
What are the different segments of the Generic Drugs Market?
Which is the fastest-growing region in the Generic Drugs market?
What growth strategies are the players considering to increase their presence in Generic Drugs ?
What are the upcoming opportunities and trends for the Generic Drugs Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Generic Drugs Market?
Who are the leading companies and what are their portfolios in Generic Drugs Market?
𝐊𝐞𝐲 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬:

Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by Different Segment | 2024-2030
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation - A detailed analysis by segment with their sub-segments and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
𝐋𝐨𝐨𝐤 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐎𝐮𝐫 𝐌𝐨𝐬𝐭 𝐏𝐨𝐩𝐮𝐥𝐚𝐫 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

• PLA Cup Market https://www.maximizemarketresearch.com/market-report/pla-cup-market/146528/

• DIY Eyelash Market https://www.maximizemarketresearch.com/market-report/diy-eyelash-market/146870/

• Construction Smart Wearable Market https://www.maximizemarketresearch.com/market-report/construction-smart-wearable-market/148665/

• Japan Baby Care Product Market https://www.maximizemarketresearch.com/market-report/japan-baby-care-product-market/122951/

• India Personal Care Packaging Market https://www.maximizemarketresearch.com/market-report/india-personal-care-packaging-market/45625/

• global post harvest treatment products market https://www.maximizemarketresearch.com/market-report/global-post-harvest-treatment-products-market/67085/

• Asia Pacific Carbon Fiber Composite Market https://www.maximizemarketresearch.com/market-report/asia-pacific-carbon-fiber-composite-market/19768/

• Automotive Fire Suppression System Market https://www.maximizemarketresearch.com/market-report/automotive-fire-suppression-system-market/77384/

• Global EV Motor Controller Market https://www.maximizemarketresearch.com/market-report/global-ev-motor-controller-market/79300/

• Global Air Transport USM Market https://www.maximizemarketresearch.com/market-report/global-air-transport-usm-market/44796/

𝐎𝐮𝐫 𝐀𝐝𝐝𝐫𝐞𝐬𝐬:

𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐯𝐭. 𝐋𝐭𝐝.

⮝ 3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

✆ +91 9607365656

🖂 sales@maximizemarketresearch.com

🌐 www.maximizemarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.